Array
(
[direction] => -1
[market_status] => red
)Last year, in May, the foreign parent of Fresenius Kabi, an Indian oncology drugs company, announced its intention to sell up to 15% promoter stake and reduce its shareholding to 75% via one or more OFS.
first published: Jun 22, 2013 02:50 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty extends loss, below 22,400 led by banking stocks | Closing Bell

Iran conflict enters 5th week, Brent above $115: what lies for Nifty? | Opening Bell

‘Attacked from 17 Directions’: Trump Says Ford Carrier Crew ‘Ran for Their Lives’

Rubio Says US ‘On Track’ in Iran War, Warns World Over Strait of Hormuz Threat
You are already a Moneycontrol Pro user.


